// App-Quantinova.ai

SAT-0982 : Analysis of the Efficacy of U-500 Regular Insulin in Patients with Type 2 Diabetes and Insulin Resistance

Researchers

Presenter

  • Walaa Ayoub

Principal Investigators

  • Ryan D Mills

  • Sunil Thomas

  • Rashim Gupta

  • Jessica Eve Shill

  • Sharon Wu Lahiri

  • Abraham Thomas

Medical Centers

  • Henry Ford Medcl Ctr, Detroit, MI

  • Henry Ford Health System, Detroit, MI

  • Henry Ford Hosp, Detroit, MI

  • Henry Ford Medcl Ctr, Detroit, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Aldo-Keto Reductase Family 1 Member C2

  • GC Vitamin D Binding Protein

  • Hemoglobin A1c

  • Insulin

  • Sex hormone binding globulin

Drug/Treatment

  • Insulin regular

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved